Literature DB >> 18440487

Role of the width of the surgical margin in a hepatectomy for small hepatocellular carcinomas eligible for percutaneous local ablative therapy.

Kazuaki Shimada1, Yoshihiro Sakamoto, Minoru Esaki, Tomoo Kosuge.   

Abstract

BACKGROUND: There is intense clinical interest to determine whether a wide surgical margin is required to improve postoperative recurrence after locoregional therapy for small hepatocellular carcinomas (HCCs).
METHODS: From 1996 to 2003, 117 patients with small HCCs, and also matching the criteria for local ablation therapy (up to 3 nodules </=30 mm in size), were analyzed retrospectively to determine the prognostic factors affecting postoperative recurrence.
RESULTS: The number of tumors and the surgical margin status were independent factors influencing the disease-free survival. The wide surgical margin status (>/=10 mm) provided a favorable disease-free survival in the 39 patients with negative hepatitis C virus infection (P = .0020) in the 59 patients with larger tumor size (>/=25 mm) (P = .0265) and in the 60 younger patients (</=63 y) (P = .0103).
CONCLUSIONS: A surgical margin (>/=10 mm) should be secured in young patients without hepatitis C virus infection and/or a tumor size of 25 mm or larger because long-term disease-free survival could be expected after a macroscopic curative hepatectomy for small HCCs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440487     DOI: 10.1016/j.amjsurg.2007.06.033

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  16 in total

Review 1.  Principles of and advances in percutaneous ablation.

Authors:  Muneeb Ahmed; Christopher L Brace; Fred T Lee; S Nahum Goldberg
Journal:  Radiology       Date:  2011-02       Impact factor: 11.105

Review 2.  Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation.

Authors:  Muneeb Ahmed; Marwan Moussa; S Nahum Goldberg
Journal:  Chem Phys Lipids       Date:  2011-12-14       Impact factor: 3.329

3.  Outcomes of non-anatomic liver resection for hepatocellular carcinoma in the patients with liver cirrhosis and analysis of prognostic factors.

Authors:  Zhi-yong Huang; Gen Chen; Xiao-yi Hao; Rong-yao Cai; Yin-feng Zhao; Xiao-ping Chen
Journal:  Langenbecks Arch Surg       Date:  2010-09-18       Impact factor: 3.445

4.  The role of postoperative radiotherapy in hepatocellular carcinoma.

Authors:  Joongyo Lee; Jinsil Seong
Journal:  Hepatobiliary Surg Nutr       Date:  2022-02       Impact factor: 7.293

5.  Adjuvant transarterial chemotherapy for margin-positive resection of hepatocellular carcinoma-a propensity score matched analysis.

Authors:  Alvina Jada Fok; Wong Hoi She; Ka Wing Ma; Simon H Y Tsang; Wing Chiu Dai; Albert C Y Chan; Chung Mau Lo; Tan To Cheung
Journal:  Langenbecks Arch Surg       Date:  2021-08-18       Impact factor: 2.895

6.  Impact on Oncological Outcomes and Intent-to-Treat Survival of Resection Margin for Transplantable Hepatocellular Carcinoma in All-Comers and in Patients with Cirrhosis: A Multicenter Study.

Authors:  Chetana Lim; Claire Goumard; Margarida Casellas-Robert; Santiago Lopez-Ben; Laura Lladó; Juli Busquets; Chady Salloum; Maria Teresa Albiol-Quer; Ernest Castro-Gutiérrez; Olivier Rosmorduc; Cyrille Feray; Emilio Ramos; Joan Figueras; Olivier Scatton; Daniel Azoulay
Journal:  World J Surg       Date:  2020-06       Impact factor: 3.352

Review 7.  Tumor ablation: common modalities and general practices.

Authors:  Erica M Knavel; Christopher L Brace
Journal:  Tech Vasc Interv Radiol       Date:  2013-12

8.  Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival.

Authors:  Theodoros Michelakos; Filippos Kontos; Yurie Sekigami; Motaz Qadan; Lei Cai; Onofrio Catalano; Vikram Deshpande; Madhukar S Patel; Teppei Yamada; Nahel Elias; Leigh Anne Dageforde; Shoko Kimura; Tatsuo Kawai; Kenneth K Tanabe; James F Markmann; Heidi Yeh; Cristina R Ferrone
Journal:  J Gastrointest Surg       Date:  2020-08-10       Impact factor: 3.452

Review 9.  Management of centrally located hepatocellular carcinoma: Update 2016.

Authors:  Wei-Bo Yu; Andrew Rao; Victor Vu; Lily Xu; Jian-Yu Rao; Jian-Xiong Wu
Journal:  World J Hepatol       Date:  2017-05-08

10.  Radiofrequency Ablation Covering the Entire Tumor Blood Drainage Area Improves Survival in Hepatocellular Carcinoma.

Authors:  Masashi Hirooka; Yohei Koizumi; Takaaki Tanaka; Kotarou Sunago; Yoshiko Nakamura; Takao Watanabe; Osamu Yoshida; Yoshio Tokumoto; Masanori Abe; Yoichi Hiasa
Journal:  Hepatol Commun       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.